Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

about

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

Item

http://www.wikidata.org/entity/Q47548478

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@en

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@nl

type

Item

label

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@en

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@nl

prefLabel

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@en

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@nl

P1476

Hepatitis B Virus Vaccination ...... the Size of HIV-1 Reservoirs?

@en

P2093

Aikaterini Nasi

http://www.w3.org/2001/XMLSchema#string

Anna Nilsson

http://www.w3.org/2001/XMLSchema#string

Rebecka Lantto Graham

http://www.w3.org/2001/XMLSchema#string

Sandra Soeria-Atmadja

http://www.w3.org/2001/XMLSchema#string

Yonas Bekele

http://www.w3.org/2001/XMLSchema#string

P2860

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents

Induced immunity against hepatitis B virus

Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.

P304

1966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01966

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29375579

http://www.w3.org/2001/XMLSchema#string

P932

5767726

http://www.w3.org/2001/XMLSchema#string